Source: Virtual Congress 2020 – New frontiers in cystic fibrosis imaging and lung physiology
Disease area: Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Stanojevic (Toronto (ON), Canada), S. Davis (Chapel Hill, United States of America), D. Sanders (Indianapolis, United States of America), L. Perem (Toronto (ON), Canada), M. Shaw (Toronto (ON), Canada), J. Guido (Toronto (ON), Canada), R. Jensen (Toronto (ON), Canada), S. Jara (Indianapolis, United States of America), C. Clem (Toronto (ON), Canada), M. Solomon (Toronto (ON), Canada), N. Sweezey (Toronto (ON), Canada), H. Grasemann (Toronto (ON), Canada), V. Waters (Toronto (ON), Canada), F. Ratjen (Toronto (ON), Canada). Early determinants of lung disease in children with cystic fibrosis. 4313

Member's Comments

No comment yet.

Related content which might interest you: Early cystic fibrosis lung disease Source: Eur Respir Monogr 2014; 64: 77-87 Year: 2014 Relations between the sinonasal development and the lung disease in cystic fibrosis patients Source: Eur Respir J 2005; 26: Suppl. 49, 103s Year: 2005 Risk factors for lung disease progression in children with cystic fibrosis Source: Eur Respir J, 52 (4) 1801492; 10.1183/13993003.01492-2018 Year: 2018 Risk factors for lung disease progression in children with cystic fibrosis Source: Eur Respir J, 51 (6) 1702509; 10.1183/13993003.02509-2017 Year: 2018 Lung function in children with cystic fibrosis liver disease Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects Year: 2021 Early renal involvement in children with cystic fibrosis. Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research Year: 2018 Factors affecting progression of lung disease among patients with cystic fibrosis Source: International Congress 2019 – Physiology of cystic fibrosis Year: 2019 Progression of lung disease detected by MRI and impact of NBS in preschool children with cystic fibrosis Source: International Congress 2019 – Advances in care and monitoring of cystic fibrosis Year: 2019 Pathophysiology of cystic fibrosis lung disease Source: Eur Respir Monogr 2014; 64: 1-13 Year: 2014 Early origin of cystic fibrosis lung disease Source: Annual Congress 2010 - Early origins of adult lung disease Year: 2010 Comparison of lung function during infancy and childhood in children with cystic fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 229s Year: 2003 Efficacy of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis and advanced lung disease Source: Eur Respir J, 57 (2) 2003079; 10.1183/13993003.03079-2020 Year: 2021 Comparison of progression in lung structure and lung function in children and adolescents with cystic fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 714s Year: 2006 Impact of CFTR modulator use on outcomes in people with severe cystic fibrosis lung disease Source: Eur Respir Rev, 29 (155) 190112; 10.1183/16000617.0112-2019 Year: 2020 Season dynamics of inflammatory markers in patients with cystic fibrosis lung disease Source: Eur Respir J 2002; 20: Suppl. 38, 528s Year: 2002 Improving airway clearance in cystic fibrosis lung disease Source: Eur Respir Monogr 2014; 64: 169-187 Year: 2014 Screening for cystic fibrosis among high risk group patients with chronic lung disease Source: Eur Respir J 2002; 20: Suppl. 38, 340s Year: 2002 Impact of lung disease on respiratory impedance in young children with cystic fibrosis Source: Eur Respir J 2015; 46: 1672-1679 Year: 2015